Glutamate receptors are implicated in several neuropsychiatric disorders and in the actions of neuroleptic drugs used to treat them. To help clarify how these drugs impinge upon the glutamatergic system, we have studied the effects of 2 weeks' haloperidol (2 mg kg-1 d-1) upon the distribution and abundance of glutamate receptor mRNAs in rat brain. The mRNAs detected were those encoding the glutamate-binding protein (GBP), the N-methyl D-aspartate (NMDA) receptor (NR1 subunit) and the flip and flop isoforms of α-amino-3-hydroxy- 5-methyl-4-isoxazolpropionate (AMPA)-preferring non-NMDA receptors gluR1 and gluR2. The mRNAs were studied using in situ hybridization histochemistry in dorsolateral striatum, nucleus accumbens, frontal cortex and hippocampus. Haloperidol led to an increase in GBP mRNA in striatum and frontal cortex but not in hippocampus. AMPA receptor mRNAs showed gene- and isoform-specific alterations in treated animals, with a significant increase in the proportion of gluR2 flip compared to gluR2 flop. The gluR1 flop:gluR2 flop ratio also increased. No differences were observed for NR1 mRNA in any area. Thus, subchronic administration of haloperidol has a molecularly and spatially specific effect upon expression of glutamate receptor-related transcripts. The data have several implications. Firstly, the enhanced expression of GBP mRNA may contribute to the alterations in other glutamatergic parameters observed after neuroleptics. Secondly, the pattern of changes for the NMDA and AMPA receptor mRNAs suggests that the alterations in density of these receptors and their mRNAs reported in schizophrenia are not an artefact of neuroleptic treatment. Finally, the specific increase in flip:flop mRNA ratio for gluR2, together with the increased proportion of gluR1 flop:gluR2 flop mRNA, is likely to affect the properties of the encoded AMPA receptors. Such changes may be relevant to the desired or undesired effects of these drugs.
Agopyan N., Krnjevic K. (1993) Effects of trifluoperazine on synaptically evoked potentials and membrane properties of CA1 pyramidal neurons of rat hippocampus in situ and in vitro. Synapse13: 10-19
2.
Allen A.E., Eaton M.J., Hoel G., Michaelis E.K. (1993) Distribution of a glutamate receptor binding protein in brain mapped by immunocytochemistry and in situ hybridization. Soc Neurosci Abstr19: 474
3.
Armstrong R.C., Montminy M.R. (1993) Transsynaptic control of gene expression. Annu Rev Neurosci16: 17-29
4.
Bernard V., LeMoine C., Bloch B. (1991) Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study. Neuroscience45: 117-126
5.
Boulter I., Hollmann M., O'Shea-Greenfield A., Hartley M., Deneris E., Maron C., Heinemann S. (1990) Molecular cloning and functional expression of glutamate receptor subunit genes. Science249: 1033-1037
6.
Breese C.R., Hall M.E., Rogers S.W., Leonard S. (1993) Characterization of glutamate receptor subunits in hippocampi from normal and schizophrenic patients. Soc Neurosci Abstr19: 340.1
7.
Buckland P.R., O'Donovan M.C., McGuffin P. (1992) Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment. Psychopharmacology106: 479-483
8.
Buckland P.R., O'Donovan M.C., McGuffin P. (1993) Clozapine and sulpiride up-regulate dopamine D 3 receptor mRNA levels. Neuropharmacology32: 901-907
9.
Burnashev N., Monyer H., Seeburg P.H., Sakmann B. (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron8: 189-198
10.
Burnet P W J, Michelson D., Smith M.A., Gold P.W., Sternberg E.M. (1994) The effect of chronic imipramine administration on the densities of 5HT1A and 5HT2 receptors and the abundances of the 5HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res638: 311-324
11.
Calabresi P., De Murtas M., Mercuri N.B., Bernardi G. (1992) Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. Ann Neurol31: 366-373
12.
Carlsson M., Carlsson A. (1990) Schizophrenia—a subcortical neurotransmitter imbalance syndrome. Schizophren Bull19: 425-432
13.
Cunningham M.D., Ferkany J.W., Enna S.J. (1993) Excitatory amino acid receptors: a gallery of new targets for pharmacological intervention. Life Sci54: 135-148
14.
Davis K.L., Kahn R.S., Ko G., Davidson M. (1991) Dopamine in schizophrenia: a review and reconceptualization . Am J Psychiatr148: 1474-1486
15.
De la Concha A., McKie J., Hodgkinson S., Mankoo B.S., Gurling H M D (1991) Stereospecific effect of flupenthixol on neuro-receptor gene expression. Mol Brain Res10: 123-127
16.
Eastwood S.L., Burnet P W J, Harrison P.J. (1994) Striatal synaptophysin expression and haloperidol-induced synaptic plasticity. Neuroreport5: 677-680
17.
Eastwood S.L., Burnett P W J, McDonald B., Clinton J., Harrison P.J. (1994a) Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience59: 881-892
18.
Eastwood S.L., Burnet P W J, Beckwith J., Kerwin R.W., Harrison P.J. (1994b) AMPA glutamate receptors and their flip and flop mRNAs in human hippocampus. Neuroreport5: 1325-1328
19.
Fishburn C.S., David C., Carmon S., Fuchs S. (1994) The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain. FEBS Lett339: 63-66
20.
Freed W.S. (1994) Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects. Neurosci Biobehav Rev18: 111-120
Gray J.A., Feldon J., Rawlins J N P, Smith A.D. (1991) The neuropsychology of schizophrenia. Behav Brain Sci14: 1-84
23.
Harrison P.J. (1993) Neuroleptic effects on neuronal and synaptic structure . In Barnes T R E (ed.), Antipsychotic drugs and their side-effects. Academic Press , London, pp. 99-110
24.
Harrison P.J., Pearson R C A (1990) In situ hybridization histochemistry and the study of gene expression in human brain. Prog Neurobiol34: 271-312
25.
Harrison P.J., Pearson R C A (1994) Principles and practice of in situ hybridization histochemistry in neuropsychiatric research. In Roberts G W, Polak J (eds), Molecular neuropathology. Cambridge University Press, Cambridge (in press)
26.
Harrison P.J., McLaughlin D., Kerwin R.W. (1991) Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet337: 450-452
27.
Havard H.L., Buckland P.R., O'Donovan M.C., McGuffin P. (1991) The effects of antidepressant drugs on kainate receptor mRNA levels. Neuropharmacology30: 675-677
28.
Hollman M., Hartley M., Heinemann S. (1991) Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science252: 851-853
29.
Jonas P., Sakmann B. (1992) Glutamate receptor channels in isolated patches from CA1 and CA3 pyramidal cells of rat hippocampal slices. J Physiol (Lond) 455: 143-171
30.
Keinanen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A., Sakmann B., Seeburg P.H. (1990) A family of AMPA-selective glutamate receptors . Science249: 556-560
31.
Kerwin R.W., Murray R.M. (1992) A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia. Schizophren Res7: 1-12
32.
Kerwin R.W., Rupniak N M J, Jenner P., Marsden C.D. (1984) A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H glutamate and [3H] acetylcholine from rat striatal slices. Neuroscience11: 205-210
33.
Kumar K.N., Tilikaratne N., Johnson P.S., Allen A.E., Michaelis E.K. (1991) Cloning of the cDNA for the glutamate-binding protein of an NMDA receptor complex. Nature354: 70-73
34.
Leonard B.L. (1993) The pharmacology of the phenothiazines, butyrophenones, thioxanthines and diphenylbutylpiperidenes. In Barnes T R E (ed.), Antipsychotic drugs and their side-effects . Academic Press, London, pp. 3-26
35.
Lieberman J.A., Koreen A.R. (1993) Neurochemistry and neuroendocrinology of schizophrenia: a selective review. Schizophren Bull19371-429
36.
Martres M.P., Sokoloff P., Giros B., Schwartz J.C. (1992) Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues. J Neurochem58: 673-679
37.
Mattson M.P., Wang H., Michaelis E.K. (1991) Developmental expression, compartmentalization, and possible role in excitotoxicity of a putative NMDA receptor protein in cultured hippocampal neurons. Brain Res565: 94-108
38.
Mayer M.L. (1991) NMDA receptors cloned at last. Nature354: 16-17
39.
Merchant K.M., Dobner P.R., Dorsa D.M. (1992) Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J Neurosci12: 652-663
40.
Mercugliano M., Saller C.F., Salama A.I., U'Prichard D.C., Chesselet M-F. (1992) Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat. Neuropsychopharmacology6: 179-187
41.
Miller J.C. (1990) Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J Neurochem54: 1453-1455
42.
Monaghan D.T., Bridges R.J., Cotman C.W. (1989) The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol29: 365-402
43.
Monyer H., Seeburg P.H., Wisden W. (1991) Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing. Neuron6: 799-810
44.
Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science256: 1217-1221
45.
Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature354: 31-37
46.
Morris B.J. (1993) Control of receptor sensitivity at the mRNA level . Mol Neurobiol7: 189-205
47.
Najlerahim A., Harrison P.J., Barton A J L, Heffernan J., Pearson R C A (1990) Distribution of messenger RNAs encoding the enzymes glutaminase, aspartate aminotransferase and glutamic acid decarboxylase in rat brain. Mol Brain Res7: 317-333
48.
Nakanishi S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science258: 597-603
49.
Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci USA89: 4270-4274
50.
Olney J.W. (1990) Excitatory aminoacids and neuropsychiatric disorders . Annu Rev Pharmacol Toxicol30: 47-71
51.
Oretti R., Spurlock G., Buckland P., McGuffin P. (1993) The effects of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brain. British Association for Psychopharmacology, Cambridge Meeting, July 1993 (abstract 106)
52.
Petralia R.S., Yokotani N., Wenthold R.J. (1994) Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci14: 667-696
53.
Pollard H., Heron A., Moreau J., Ben-Ari Y., Krestchatisky M. (1993) Alterations of the gluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience57: 545-554
54.
Rupniak N M J, Iversen S.D. (1993) Prediction of antipsychotic activity. In Barnes T R E (ed.), Antipsychotic drugs and their side-effects. Academic Press, London, pp. 87-98
55.
Sommer B., Keinanen K., Verdoorn T.A., Wisden W., Burnashev N., Herb A., Kohler M., Takagi T., Sakmann B., Seeburg P.H. (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science249: 1580-1585
56.
Ulas J., Cotman C. (1993) Excitatory aminoacid receptors in schizophrenia . Schizophren Bull19: 105-117
57.
Ulas J., Nguyen L., Cotman C.W. (1993) Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. Neuroreport4: 1049-1051
58.
Verdoorn T.A., Burnashev N., Monyer H., Seeburg P.H., Sakmann B. (1991) Structural determinants of ion flow through recombinant glutamate receptor channels. Science252: 1715-1718
59.
Wiesner R.J., Zak R. ( 1991) Quantitative approaches for studying gene expression. Am J Physiol260: L179-188
60.
Zorumski C.F., Thio L.L. (1992) Properties of vertebrate glutamate receptors: calcium mobilization and desensitization. Prog Neurobiol39: 295-336
